Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen's Protein Analysis Technology Gets US Patent

Premium

NEW HAVEN, Conn.--CuraGen was granted a US patent for specific aspects of its PathCalling protein analysis technology. Specifically, the patent covers the use of the yeast two-hybrid system in an ultra high-throughput manner, which the company employs to identify protein-protein interactions across entire genomes.

Filed under